We reported mutations in TERC[9] and telomerase reverse transcriptase (TERT) [10] to be risk factors for apparently acquired aplastic anemia, a marrow failure disease occurring in patients who lack the typical physical anomalies and family history of dyskeratosis congenita. This evidence concerns the gene TERC and dyskeratosis congenita.